The Association of Protein-Energy Adequacy With Mortality in Critically Ill Patients With Acute Kidney Injury.
1 other identifier
observational
185
1 country
1
Brief Summary
This is a prospective observational single-center study in which the association of Protein-Energy Adequacy and 28-Days of Mortality among critically ill patients with Acute Kidney Injury, AKI will be investigated. The association of Protein-Energy adequacy with a length of ICU and hospital stay, total ventilator, and inotropic drug days among critically ill patients with AKI also will be investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 20, 2020
CompletedFirst Submitted
Initial submission to the registry
August 27, 2020
CompletedFirst Posted
Study publicly available on registry
August 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2021
CompletedSeptember 3, 2020
September 1, 2020
12 months
August 27, 2020
September 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
28-Days Mortality
Mortality status of subjects on day 28 from recruitment.
1 day
Secondary Outcomes (2)
Length of ICU Stay
1 day
Length of Ventilator Day
1 day
Eligibility Criteria
This study will be conducted in adult Intensive Care Unit, University Malaya Medical Centre (UMMC), Malaysia.
You may qualify if:
- Patients who are 18 years old and older
- Patients who are admitted to the participating ICU.
- Patients who are mechanically ventilated.
You may not qualify if:
- Patients who are less than 18 years old
- End-stage renal disease patients
- Patients undergo kidney transplantation within 3 months before ICU admission
- Pregnant patients
- The patient is moribund with expected death within 24 hour or whom survival to 28 days is unlikely due to uncontrollable comorbidity (cardiac, pulmonary or hepatic end-stage disease; hepatorenal syndrome; poorly controlled cancer; severe post-anoxic encephalopathy and others)
- Prior treatment with RRT within 30 days
- Anticipated alive ICU discharge within 24 hours
- Readmission to the ICU during the same hospitalization episode.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Malaya Medical Centre
Kuala Lumpur, 59100, Malaysia
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
MOHD SHAHNAZ HASAN, MBBS
University of Malaya
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 28 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator.
Study Record Dates
First Submitted
August 27, 2020
First Posted
August 31, 2020
Study Start
July 20, 2020
Primary Completion
July 1, 2021
Study Completion
August 1, 2021
Last Updated
September 3, 2020
Record last verified: 2020-09